Published in Stroke on February 01, 1996
Guidelines for the use of carotid endarterectomy: current recommendations from the Canadian Neurosurgical Society. CMAJ (1997) 0.86
Reversible cerebral hyperperfusion syndrome after stenting of the carotid artery - two case reports. Clin Res Cardiol (2006) 0.77
Carotid angioplasty and stenting: current status. CMAJ (2000) 0.76
Angioplasty and stenting in the carotid and vertebral arteries. Postgrad Med J (1998) 0.75
Concern about safety of carotid angioplasty. Stroke (1996) 0.75
Concerns regarding carotid artery angioplasty and stenting. Stroke (1996) 0.75
Concern about safety of carotid angioplasty. Stroke (1996) 0.75
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27
Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest (1983) 6.05
Prevention of venous thromboembolism. Chest (2001) 5.59
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med (2001) 4.56
Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol (1971) 3.92
Mechanisms of stenosis after arterial injury. Lab Invest (1983) 3.75
Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res (1972) 3.53
The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke (1999) 3.31
Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature (1977) 3.25
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation (1998) 3.25
Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation (1996) 3.23
Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke (1995) 2.86
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation (1999) 2.77
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest (1990) 2.69
Prevention of venous thromboembolism. Chest (1995) 2.69
Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest (1992) 2.62
Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation (2001) 2.59
Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res (1994) 2.49
Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study. Stroke (1991) 2.42
Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem (2001) 2.40
Percutaneous ultrasound guided thrombin injection: a new method for treating postcatheterization femoral pseudoaneurysms. J Vasc Surg (1998) 2.39
The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA (1995) 2.38
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest (1992) 2.35
Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res (1985) 2.28
Expression of inducible nitric oxide synthase in human heart failure. Circulation (1996) 2.26
Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study. Am J Epidemiol (1997) 2.17
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A (1995) 2.14
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation (1999) 2.14
Real-time color duplex scanning after sclerotherapy of the greater saphenous vein. J Vasc Surg (1991) 2.10
Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg (2008) 2.10
Endovascular surgery credentialing and training for vascular surgeons. J Vasc Surg (1993) 2.02
Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res (1980) 2.00
Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation (1998) 2.00
Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res (1988) 1.91
Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest (1986) 1.91
Current status of noninvasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am (1982) 1.87
Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance. Ann Surg (1980) 1.85
Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation (2000) 1.81
Prevention of venous thromboembolism. Chest (1992) 1.81
Does low-dose aspirin therapy complicate oral surgical procedures? J Am Dent Assoc (2000) 1.79
Surgical handicraft: teaching and learning surgical skills. Am J Surg (1987) 1.77
Expanded indications for ultrasound-guided thrombin injection of pseudoaneurysms. J Vasc Surg (2000) 1.77
Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.76
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A (1992) 1.76
Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest (1983) 1.75
Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A (1989) 1.74
Hyperparathyroidism associated with malignant tumors of nonparathyroid origin. Cancer (1969) 1.73
Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation (1995) 1.73
Computed tomography scanning findings associated with rapid expansion of abdominal aortic aneurysms. J Vasc Surg (1994) 1.72
Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability--the ARIC study. Atherosclerosis Risk in Communities. Am J Cardiol (1995) 1.71
Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest (1995) 1.71
Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol (1984) 1.71
The effect of protein restriction on the progression of renal insufficiency. N Engl J Med (1989) 1.70
Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol (1987) 1.67
Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol (1996) 1.66
Ruptured abdominal aortic aneurysm: the Harborview experience. J Vasc Surg (1991) 1.66
Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. Circulation (1996) 1.65
Thoracic outlet arterial compression: prevalence in normal persons. Angiology (1980) 1.61
Reflux nephropathy and primary vesicoureteric reflux in adults. Q J Med (1990) 1.60
The FDA report on intraocular lenses. Ophthalmology (1983) 1.60
Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney Int (2001) 1.60
Carotid-subclavian bypass: a twenty-two-year experience. J Vasc Surg (1994) 1.59
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res (1989) 1.58
L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res (1990) 1.55
Transcutaneous PO2 measurements in health and peripheral arterial occlusive disease. Surgery (1982) 1.54
Steal syndrome complicating hemodialysis access. Cardiovasc Surg (1997) 1.54
No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (1995) 1.54
Mathematic coupling of data: a common source of error. Ann Surg (1981) 1.54
Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol (2001) 1.53
Carotid patch angioplasty: immediate and long-term results. J Vasc Surg (1990) 1.53
Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation (2000) 1.51
Use of sequential B-mode ultrasonography to manage abdominal aortic aneurysms. Arch Surg (1989) 1.51
Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. Stroke (1995) 1.51
Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab Invest (1985) 1.49
Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity. J Vasc Surg (1995) 1.49
Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis (1990) 1.49
Technical advances in transjugular intrahepatic portosystemic shunts. Radiographics (1992) 1.48
Intracranial placement of a nasogastric tube. AJNR Am J Neuroradiol (1989) 1.48
Delayed presentation of carotid intimal tear following blunt craniocervical trauma. Surgery (1974) 1.47
Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. J Vasc Interv Radiol (1991) 1.47
Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg (1987) 1.47
Effects of intraaortic balloon counterpulsation on the severity of myocardial ischemic injury following acute coronary occlusion. Counterpulsation and myocardial injury. Circulation (1972) 1.46
Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res (2000) 1.46
Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch Surg (1984) 1.46
eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res (2001) 1.45
Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest (1998) 1.44
Timing of postcarotid complications: a guide to safe discharge planning. J Vasc Surg (2001) 1.42
Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am J Pathol (1986) 1.41
Alterations in serum creatine kinase and lactate dehydrogenase. Association with abdominal aortic surgery, myocardial infarction and bowel necrosis. Chest (1990) 1.41
Assessing risk associated with carotid endarterectomy. A statement for health professionals by an Ad Hoc Committee on Carotid Surgery Standards of the Stroke Council, American Heart Association. Circulation (1989) 1.41
Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2000) 1.41
Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts. Circ Res (1991) 1.41
Mechanisms of arterial and aneurysmal tortuosity. Surgery (1988) 1.40